Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts

Molecular and Cellular Biochemistry

Volumn 378, Issue 1-2, 2013, Pages 217-228

  Parthasarathy, Arumugam ^a   Gopi, Venkatachalam ^a   Umadevi, Subramanian ^a   Simna, Anoop ^a   Sheik, Mohammed Jainuddin Yousuf ^a   Divya, H ^a   Vellaichamy, Elangovan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Angiotensin II; Atrial natriuretic peptide; Extracellular matrix; Matrix metallo proteinases; Natriuretic peptide receptor A

Indexed keywords

8 BROMO CYCLIC GMP; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NATRIURETIC PEPTIDE RECEPTOR A; REACTIVE OXYGEN METABOLITE; ATRIAL NATRIURETIC FACTOR RECEPTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; MMP2 PROTEIN, RAT; MMP9 PROTEIN, RAT; SMALL INTERFERING RNA;

ADULT; ANIMAL CELL; ARTICLE; CARDIAC FIBROBLAST; CELL LEVEL; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REPRESSION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION REGULATION; HEART MUSCLE FIBROSIS; INTRACELLULAR TRANSPORT; MALE; MITOSIS INHIBITION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; CYTOLOGY; GENE SILENCING; GENETICS; HEART MUSCLE; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; ATRIAL NATRIURETIC FACTOR; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCARDIUM; NF-KAPPA B; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84886783208     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1612-z     Document Type: Article

References (61)

1. Weber KT, Sun Y, Tyagi SC, Cleutjens JP (1994) Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. Am Heart J 116:1641-1646
2. Berk BC, Fujiwara K, Lehoux S (2007) ECM remodeling in hypertensive heart disease. J Clin Invest 117:568-575
3. Anderson KR, Sutton M.G., Lie JT (1979) Histopathological types of cardiac fibrosis in myocardial disease. J Pathol 128:79-85
4. Pandey KN (2005) Biology of natriuretic peptides and their receptors. Peptides 26:901-932
5. Vellaichamy E, Khurana ML, Fink J, Pandey KN (2005) Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylylcyclase/natriuretic peptide receptor A. J Biol Chem 280:19230-19242
6. Patel JB, Valencik ML, Pritchett AM, Burnett JC Jr, McDonald JA, Redfield MM (2005) Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload. Am J Physiol Heart Circ Physiol 289:777-784
7. Kishimoto I, Tokudome T, Horio T, Garbers DL, Nakao K, Kangawa K (2009) Natriuretic peptide signaling via guanylyl cyclase (GC)-A: an endogenous protective mechanism of the heart. Curr Cardiol Rev 5:45-51
8. Franco V, Chen YF, Oparil S, Feng JA, Wang D, Hage F, Perry G (2004) Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling. Hypertension 44:746-750
9. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci 94:14730-14735
10. Ellmers LJ, Knowles JW, Kim HS, Smithies O, Maeda N, Cameron VA (2002) Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis. Am J Physiol Heart Circ Physiol 283:H707-H714
11. Tsuneyoshi H, Nishina T, Nomoto T, Kanemitsu H, Kawakami R, Unimonh O, Nishimura K, Komeda M (2004) Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair. Circulation 110:174-179
12. Maki T, Horio T, Yoshihara F, Suga S, Takeo S, Matsuo H, Kangawa K (2000) Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts. Br J Pharmacol 131:1204-1210
13. Fujisaki H, Ito H, Hirata Y, Tanaka M, Hata M, Lin M, Adachi S, Akimoto H, Marumo F, Hiroe M (1995) Natriuretic peptides inhibit angiotensin II induced proliferation of rat cardiac fibroblast by blocking endothelin-1 gene expression. J Clin Invest 96:1059-1065
14. Glenn D.J., Rahmutula D, Nishimoto M, Liang F, Gardner DG (2009) Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. Cardiovasc Res 84:209-217
15. Tripathi S, Pandey KN (2012) Guanylylcyclase/natriuretic peptide receptor-A signaling antagonizes the vascular endothelial growth factor-stimulated MAPKs and downstream effectors AP-1 and CREB in mouse mesangial cells. Mol Cell Biochem 368:47-59
16. Hutchinson HG, Trindade PT, Cunanan DB, Wu CF, Pratt RE (1997) Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc Res 35: 158-167
17. Vellaichamy E, Khurana ML, Fink J, Pandey KN (2007) Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-A. Peptides 28:893-899
18. Brilla CG, Zhou G, Matsubara L, Weber KT (1994) Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 26:809-820
19. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, Kinugawa S, Tsutsui H (2006) Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload. Hypertension 47:711-717
20. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55-62
21. Kumar S, Seqqat R, Chigurupati S, Kumar R, Baker KM, Young D, Sen S, Gupta S (2011) Inhibition of nuclear factor κB regresses cardiac hypertrophy by modulating the expression of extracellular matrix and adhesion molecules. Free Radic Biol Med 50:206-215
22. Pathak M, Sarkar S, Vellaichamy E, Sen S (2001) Role of myocytes in myocardial collagen production. Hypertension 37:833-840
23. Bergman I, Loxley R (1963) Two improved and simplified methods for the spectrophotometric determination of hydroproline. Anal Chem 35:1961-1965
24. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, Namba M (1998) Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98:794-799
25. Xu J, Carretero OA, Liao TD, Peng H, Shesely EG, Xu J, Liu TS, Yang JJ, Reudelhuber TL, Yang XP (2010) Local angiotensin II aggravates cardiac remodeling in hypertension. Am J Physiol Heart Circ Physiol 299:1328-1338
26. Yasuda N, Akazawa H, Ito K, Shimizu I, Kudo-Sakamoto Y, Yabumoto C, Yano M, Yamamoto R, Ozasa Y, Minamino T, Naito AT, Oka T, Shiojima I, Tamura K, Umemura S, Paradis P, Nemer M, Komuro I (2012) Agonist-independent constitutive activity of angiotensin II receptor promotes cardiac remodeling in mice. Hypertension 59:627-633
27. Porter KE, Turner NA (2009) Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123:255-278
28. Manabe I, Shindo T, Nagai R (2002) Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91:1103-1113
29. Tripathi S, Pandey KN (2012) Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes the vascular endothelial growth factor-stimulated MAPKs and downstream effectors AP-1 and CREB in mouse mesangial cells. Mol Cell Biochem 368:47-59
30. O'Tierney PF, Chattergoon NN, Louey S, Giraud GD, Thornburg KL (2010) Atrial natriuretic peptide inhibits angiotensin IIstimulated proliferation in fetal cardiomyocytes. J Physiol 1:2879-2889
31. Skelton WP 4th, Pi G, Lenz A, Sun Y, Vesely DL (2010) Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells. Eur J Clin Invest 40:706-712
32. Vesely BA, Song S, Sanchez-Ramos J, Fitz SR, Solivan SM, Gower WR Jr, Vesely DL (2005) Four peptide hormones decrease the number of human breast adenocarcinoma cells. Eur J Clin Invest 35:60-69
33. Glenn D.J., Rahmutula D, Nishimoto M, Liang F, Gardner DG (2009) Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. Cardiovasc Res 84:209-217
34. Abdelalim EM, Tooyama I (2011) NPR-A regulates self-renewal and pluripotency of embryonic stem cells. Cell Death Dis 2:e127
35. You H, Laychock SG (2009) Atrial natriuretic peptide promotes pancreatic islet beta-cell growth and Akt/Foxo1a/cyclin D2 signaling. Endocrinology 150:5455-5465
36. Wang X, Raulji P, Mohapatra SS, Patel R, Hellermann G, Kong X, Vera PL, Meyer-Siegler KL, Coppola D, Mohapatra S (2011) Natriuretic peptide receptor a as a novel target for prostate cancer. Mol Cancer 10:56
37. Lelie'vre V, Pineau N, Hu Z, Ioffe Y, Byun JY, Muller JM, Waschek JA (2001) Proliferative actions of natriuretic peptides on neuroblastoma cells. Involvement of guanylyl cyclase and non-guanylyl cyclase pathways. J Biol Chem 276(47):43668-43676
38. Redondo J, Bishop JE, Wilkins MR (1998) Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts. Br J Pharmacol 124:1455-1462
39. Tamamori M, Ito H, Hiroe M, Marumo F, Hata RI (1997) Stimulation of collagen synthesis in rat cardiac fibroblasts by exposure to hypoxic culture conditions and suppression of the effect by natriuretic peptides. Cell Biol Int 21:175-180
40. Weber KT, Sun Y, Katwa LC (1997) Myofibroblasts and local angiotensin II in rat cardiac tissue repair. Int J Biochem Cell Biol 29:31-42
41. Wang D, Oparil S, Feng JA, Li P, Perry G, Chen LB, Dai M, John SW, Chen YF (2003) Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse. Hypertension 42:88-95
42. Knowles JW, Esposito G, Mao L, Hagaman JR, Fox JE, Smithies O, Rockman HA, Maeda N (2001) Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 107:975-984
43. Spinale FG, Gunasinghe H, Sprunger PD, Baskin JM, Bradham WC (2002) Extracellular degradative pathways in myocardial remodeling and progression to heart failure. J Card Fail 8:S332-S338
44. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J (2004) Matrix metalloproteinases and their tissue inhibitors in pressureoverloaded human myocardium during heart failure progression. J Am Coll Cardiol 44:1609-1618
45. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP (1988) Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-Llysine-Cu2+. FEBS Lett 238:343-346
46. Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC, Feldman AM (2000) Myocardial extracellular matrix remodeling in transgenic mice over expressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci 97:12746-12751
47. Wang M, Zhang J, Walker SJ, Dworakowski R, Lakatta EG, Shah AM (2010) Involvement of NADPH oxidase in age-associated cardiac remodeling. J Mol Cell Cardiol 48:765-772
48. Santiago JJ, Dangerfield AL, Rattan SG, Bathe KL, Cunnington RH, Raizman JE, Bedosky KM, Freed DH, Kardami E, Dixon IM (2010) Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev Dyn 239:1573-1584
49. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148
50. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R (2000) A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87:26-32
51. Grieve D.J., Byrne JA, Siva A, Layland J, Johar S, Cave AC, Shah AM (2006) Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol 47:817-826
52. Chen K, Chen J, Li D, Zhang X, Mehta JL (2004) Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension 44:655-661
53. Perez-Cruz I, Carcamo JM, Golde DW (2003) Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells. Blood 102(1):336-343
54. Giftson JS, Jayanthi S, Nalini N (2010) Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs 28(3):251-259
55. Laskowski A, Woodman OL, Cao AH, Drummond GR, Marshall T, Kaye DM, Ritchie RH (2006) Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 72:112-123
56. Poitevin S, Garnotel R, Antonicelli F, Gillery P, Nguyen P (2008) Type I collagen induces tissue factor expression and matrix metalloproteinase 9 production in human primary monocytes through a redox-sensitive pathway. J Thromb 6:1586-1594
57. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253:269-285
58. Kim JM, Heo HS, Choi YJ, Ye BH, Mi Ha Y, Seo AY, Yu BP, Leeuwenburgh C, Chung HY, Carter CS (2011) Inhibition of NFκB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney. Exp Gerontol 46:542-548
59. Yeh CB, Hsieh MJ, Hsieh YH, Chien MH, Chiou HL, Yang SF (2012) Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition ofMMP-9 through modulation of NF-κB activity. PLoS ONE 7:31055
60. Bond M, Chase AJ, Baker AH, Newby AC (2001) Inhibition of transcription factor nf-kappa b reduces matrix metalloproteinase-1,-3 and-9 production by vascular smooth muscle cells. Cardiovasc Res 50:556-565
61. Gupta S, Purcell NH, Lin A, Sen S (2002) Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 159:1019-1028